Cargando…

In silico design of MHC class I high binding affinity peptides through motifs activation map

BACKGROUND: Finding peptides with high binding affinity to Class I major histocompatibility complex (MHC-I) attracts intensive research, and it serves a crucial part of developing a better vaccine for precision medicine. Traditional methods cost highly for designing such peptides. The advancement of...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Zhoujian, Zhang, Yuwei, Yu, Runsheng, Chen, Yin, Jiang, Xiaosen, Wang, Ziwei, Li, Shuaicheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311935/
https://www.ncbi.nlm.nih.gov/pubmed/30598069
http://dx.doi.org/10.1186/s12859-018-2517-3
_version_ 1783383705124864000
author Xiao, Zhoujian
Zhang, Yuwei
Yu, Runsheng
Chen, Yin
Jiang, Xiaosen
Wang, Ziwei
Li, Shuaicheng
author_facet Xiao, Zhoujian
Zhang, Yuwei
Yu, Runsheng
Chen, Yin
Jiang, Xiaosen
Wang, Ziwei
Li, Shuaicheng
author_sort Xiao, Zhoujian
collection PubMed
description BACKGROUND: Finding peptides with high binding affinity to Class I major histocompatibility complex (MHC-I) attracts intensive research, and it serves a crucial part of developing a better vaccine for precision medicine. Traditional methods cost highly for designing such peptides. The advancement of computational approaches reduces the cost of new drug discovery dramatically. Compared with flourishing computational drug discovery area, the immunology area lacks tools focused on in silico design for the peptides with high binding affinity. Attributed to the ever-expanding amount of MHC-peptides binding data, it enables the tremendous influx of deep learning techniques for modeling MHC-peptides binding. To leverage the availability of these data, it is of great significance to find MHC-peptides binding specificities. The binding motifs are one of the key components to decide the MHC-peptides combination, which generally refer to a combination of some certain amino acids at certain sites which highly contribute to the binding affinity. RESULT: In this work, we propose the Motif Activation Mapping (MAM) network for MHC-I and peptides binding to extract motifs from peptides. Then, we substitute amino acid randomly according to the motifs for generating peptides with high affinity. We demonstrated the MAM network could extract motifs which are the features of peptides of highly binding affinities, as well as generate peptides with high-affinities; that is, 0.859 for HLA-A*0201, 0.75 for HLA-A*0206, 0.92 for HLA-B*2702, 0.9 for HLA-A*6802 and 0.839 for Mamu-A1*001:01. Besides, its binding prediction result reaches the state of the art. The experiment also reveals the network is appropriate for most MHC-I with transfer learning. CONCLUSIONS: We design the MAM network to extract the motifs from MHC-peptides binding through prediction, which are proved to generate the peptides with high binding affinity successfully. The new peptides preserve the motifs but vary in sequences.
format Online
Article
Text
id pubmed-6311935
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63119352019-01-07 In silico design of MHC class I high binding affinity peptides through motifs activation map Xiao, Zhoujian Zhang, Yuwei Yu, Runsheng Chen, Yin Jiang, Xiaosen Wang, Ziwei Li, Shuaicheng BMC Bioinformatics Methodology BACKGROUND: Finding peptides with high binding affinity to Class I major histocompatibility complex (MHC-I) attracts intensive research, and it serves a crucial part of developing a better vaccine for precision medicine. Traditional methods cost highly for designing such peptides. The advancement of computational approaches reduces the cost of new drug discovery dramatically. Compared with flourishing computational drug discovery area, the immunology area lacks tools focused on in silico design for the peptides with high binding affinity. Attributed to the ever-expanding amount of MHC-peptides binding data, it enables the tremendous influx of deep learning techniques for modeling MHC-peptides binding. To leverage the availability of these data, it is of great significance to find MHC-peptides binding specificities. The binding motifs are one of the key components to decide the MHC-peptides combination, which generally refer to a combination of some certain amino acids at certain sites which highly contribute to the binding affinity. RESULT: In this work, we propose the Motif Activation Mapping (MAM) network for MHC-I and peptides binding to extract motifs from peptides. Then, we substitute amino acid randomly according to the motifs for generating peptides with high affinity. We demonstrated the MAM network could extract motifs which are the features of peptides of highly binding affinities, as well as generate peptides with high-affinities; that is, 0.859 for HLA-A*0201, 0.75 for HLA-A*0206, 0.92 for HLA-B*2702, 0.9 for HLA-A*6802 and 0.839 for Mamu-A1*001:01. Besides, its binding prediction result reaches the state of the art. The experiment also reveals the network is appropriate for most MHC-I with transfer learning. CONCLUSIONS: We design the MAM network to extract the motifs from MHC-peptides binding through prediction, which are proved to generate the peptides with high binding affinity successfully. The new peptides preserve the motifs but vary in sequences. BioMed Central 2018-12-31 /pmc/articles/PMC6311935/ /pubmed/30598069 http://dx.doi.org/10.1186/s12859-018-2517-3 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology
Xiao, Zhoujian
Zhang, Yuwei
Yu, Runsheng
Chen, Yin
Jiang, Xiaosen
Wang, Ziwei
Li, Shuaicheng
In silico design of MHC class I high binding affinity peptides through motifs activation map
title In silico design of MHC class I high binding affinity peptides through motifs activation map
title_full In silico design of MHC class I high binding affinity peptides through motifs activation map
title_fullStr In silico design of MHC class I high binding affinity peptides through motifs activation map
title_full_unstemmed In silico design of MHC class I high binding affinity peptides through motifs activation map
title_short In silico design of MHC class I high binding affinity peptides through motifs activation map
title_sort in silico design of mhc class i high binding affinity peptides through motifs activation map
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311935/
https://www.ncbi.nlm.nih.gov/pubmed/30598069
http://dx.doi.org/10.1186/s12859-018-2517-3
work_keys_str_mv AT xiaozhoujian insilicodesignofmhcclassihighbindingaffinitypeptidesthroughmotifsactivationmap
AT zhangyuwei insilicodesignofmhcclassihighbindingaffinitypeptidesthroughmotifsactivationmap
AT yurunsheng insilicodesignofmhcclassihighbindingaffinitypeptidesthroughmotifsactivationmap
AT chenyin insilicodesignofmhcclassihighbindingaffinitypeptidesthroughmotifsactivationmap
AT jiangxiaosen insilicodesignofmhcclassihighbindingaffinitypeptidesthroughmotifsactivationmap
AT wangziwei insilicodesignofmhcclassihighbindingaffinitypeptidesthroughmotifsactivationmap
AT lishuaicheng insilicodesignofmhcclassihighbindingaffinitypeptidesthroughmotifsactivationmap